-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Avalon Investment & Advisory Has $4.20 Million Position in InMode Ltd. (NASDAQ:INMD)
Avalon Investment & Advisory Has $4.20 Million Position in InMode Ltd. (NASDAQ:INMD)
Avalon Investment & Advisory lowered its position in InMode Ltd. (NASDAQ:INMD – Get Rating) by 6.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 144,420 shares of the healthcare company's stock after selling 9,640 shares during the quarter. Avalon Investment & Advisory owned approximately 0.17% of InMode worth $4,204,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Whittier Trust Co. of Nevada Inc. increased its position in InMode by 7.4% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 29,939 shares of the healthcare company's stock worth $670,000 after acquiring an additional 2,072 shares during the period. Point72 Asset Management L.P. bought a new position in InMode in the 2nd quarter valued at about $5,479,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in InMode by 614.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 36,947 shares of the healthcare company's stock valued at $828,000 after buying an additional 31,773 shares during the period. Advisory Services Network LLC increased its holdings in InMode by 7.1% in the 1st quarter. Advisory Services Network LLC now owns 89,064 shares of the healthcare company's stock valued at $3,287,000 after buying an additional 5,920 shares during the period. Finally, Baltimore Washington Financial Advisors Inc. increased its holdings in InMode by 99.2% in the 2nd quarter. Baltimore Washington Financial Advisors Inc. now owns 288,344 shares of the healthcare company's stock valued at $6,461,000 after buying an additional 143,576 shares during the period. Institutional investors and hedge funds own 55.24% of the company's stock.
Get InMode alerts:InMode Trading Down 0.6 %
INMD opened at $32.70 on Friday. The company's 50 day moving average is $35.83 and its 200-day moving average is $32.80. InMode Ltd. has a 1-year low of $20.60 and a 1-year high of $54.68. The company has a market cap of $2.72 billion, a P/E ratio of 15.80 and a beta of 2.19.
InMode (NASDAQ:INMD – Get Rating) last posted its earnings results on Thursday, October 27th. The healthcare company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.63 by ($0.05). InMode had a return on equity of 39.52% and a net margin of 40.93%. The business had revenue of $121.23 million for the quarter, compared to analyst estimates of $120.70 million. On average, equities analysts forecast that InMode Ltd. will post 2.09 EPS for the current year.Analyst Ratings Changes
Several equities analysts have commented on INMD shares. Barclays started coverage on shares of InMode in a report on Wednesday, December 21st. They issued an "overweight" rating and a $44.00 target price on the stock. TheStreet lowered shares of InMode from a "b-" rating to a "c+" rating in a report on Tuesday, September 20th. Finally, Jefferies Financial Group started coverage on shares of InMode in a report on Wednesday, October 12th. They issued a "buy" rating and a $40.00 target price on the stock. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $46.17.
About InMode
(Get Rating)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Recommended Stories
- Get a free copy of the StockNews.com research report on InMode (INMD)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here's Why
- Carvana Stock Rally, Here's What You Need to Know
Want to see what other hedge funds are holding INMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InMode Ltd. (NASDAQ:INMD – Get Rating).
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
根據納斯達克最近向美國證券交易委員會(Securities and Exchange Commission,簡稱美國證券交易委員會)披露的資訊,該公司在第三季度將其在納斯達克的持倉下調了6.3%。該基金在本季度出售了9640股後,持有這家醫療保健公司的144,420股股票。截至最近一次報告期末,Avalon Investment&Consulting擁有InMode約0.17%的股份,價值4,204,000美元。
其他大型投資者最近也增持或減持了該公司的股份。內華達公司的Whittier Trust Co.在第二季度將其在InModel的持倉增加了7.4%。內華達公司的Whittier Trust Co.在此期間增持了2,072股惠蒂爾股票,目前持有該公司29,939股股票,價值67萬美元。Point72 Asset Management L.P.在第二季度購買了InMode的一個新頭寸,價值約5,479,000美元。Zurcher Kantonalbank秀克黎世廣州銀行在第二季度增持了614.1%的InMode股份。Zurcher Kantonalbank秀克黎世廣東銀行目前持有這家醫療保健公司的36,947股股票,價值828,000美元,在此期間又購買了31,773股。諮詢服務網路有限責任公司在第一季度增持了7.1%的InModel股份。諮詢服務網路有限責任公司現在擁有89,064股這家醫療保健公司的股票,價值3,287,000美元,在此期間又購買了5,920股。最後,巴爾的莫耳華盛頓金融顧問公司(Baltimore Washington Financial Advisors Inc.)在第二季度增持了InModel 99.2%的股份。巴爾的莫耳華盛頓金融顧問公司(Baltimore Washington Financial Advisors Inc.)目前持有這家醫療保健公司288,344股股票,價值6461,000美元,在此期間又購買了143,576股。機構投資者和對沖基金持有該公司55.24%的股票。
到達在模式下警報:InMode股價下跌0.6%
INMD上週五開盤報32.70美元。該公司的50日移動均線切入位在35.83美元,200日移動均線切入位在32.80美元。InModeLtd.的股價跌至20.60美元的一年低點和54.68美元的一年高點。該公司市值27.2億美元,本益比為15.80倍,貝塔係數為2.19倍。
納斯達克(股價代碼:INMD-GET Rating)最近一次公佈財報是在10月27日星期四。這家醫療保健公司公佈本季度每股收益為0.58美元,低於普遍預期的0.63美元(0.05美元)。InMode的股本回報率為39.52%,淨利潤率為40.93%。該業務本季度營收為1.2123億美元,而分析師預期為1.207億美元。股票分析師平均預測,InModeLtd.本年度每股收益將達到2.09歐元。分析師評級發生變化
幾位股票分析師對INMD的股票發表了評論。巴克萊在12月21日星期三的一份報告中開始了對InMode股票的報道。他們對該股的評級為“增持”,目標價為44.00美元。華爾街在9月20日星期二的一份報告中將InMode的股票評級從“b-”下調至“c+”。最後,傑富瑞金融集團在10月12日星期三的一份報告中開始對InMode的股票進行報道。他們對該股的評級為“買入”,目標價為40美元。根據MarketBeat的數據,五位股票研究分析師對該股的評級為買入,該公司目前的普遍評級為買入,平均目標價為46.17美元。
關於InMode
(獲取評級)
InModel有限公司在美國和國際上設計、開發、製造和銷售基於其專有的射頻輔助脂肪分解和深皮下部分射頻技術的微創美容醫療產品。該公司提供用於各種手術的微創美容醫療產品,如同時收緊皮膚的吸脂術、身體和麵部輪廓以及消融性皮膚年輕療法,以及用於女性健康狀況和手術的產品。
推薦故事
- 免費獲取StockNews.com關於InMode(INMD)的研究報告
- MarketBeat:回顧中的一週01/09-01/13
- 摩根大通破產,銀行為衰退做好準備
- 為什麼Bed Bath&Beyond的股價上漲了261%?
- Roku股價走勢,原因如下
- Carvana Stock Rally,這是你需要知道的
想看看其他對沖基金持有哪些INMD嗎?訪問HoldingsChannel.com獲取InModelLtd.(納斯達克代碼:INMD-GET Rating)的最新13F備案檔案和內幕交易資訊。
接收InMode Daily的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對InMode和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧